ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing (2021)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12879-020-05672-6
PubMed Identifier: 33446115
Publication URI: http://europepmc.org/abstract/MED/33446115
Type: Journal Article/Review
Parent Publication: BMC Infectious Diseases
Issue: 1
ISSN: 1471-2334